← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 30, 2020Last known activity
May 31, 2025
Timeline
2010s
- Jun 22, 2015
ITB-Med LLC— Founded
Drugs by trial phase (14 distinct, 13 trials)
Phase 2 (13 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Recent trials (19)
- NCT06972069CollaboratorEarly Phase 1May 31, 2025
- NCT06326476CollaboratorEarly Phase 1Jan 31, 2025
- NCT06455280CollaboratorPhase 1Sep 11, 2024
- NCT06453668Lead sponsorPhase 1Apr 16, 2024
- NCT06453668OfficialPhase 1Apr 16, 2024
- NCT05900401CollaboratorPhase 1/Phase 2Oct 1, 2023
- NCT06078696CollaboratorPhase 1/Phase 2Sep 28, 2023
- NCT05669001Lead sponsorPhase 2Apr 30, 2023
- NCT05669001Study directorPhase 2Apr 30, 2023
- NCT06025110Lead sponsorPhase 2Jan 23, 2023
- NCT06025110Study directorPhase 2Jan 23, 2023
- NCT06019507Lead sponsorPhase 2Jun 29, 2022
- NCT06019507Study directorPhase 2Jun 29, 2022
- NCT04803058Lead sponsorPhase 2Jul 31, 2021
- NCT04803006Lead sponsorPhase 2Jul 31, 2021
Details
- Founded
- Stockholm, SE Jun 22, 2015
- Last known activity
- May 31, 2025